News
1h
Vietnam Investment Review on MSNAscletis Completes Dosing in US Obesity Drug Combo TrialAscletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that all the 28 participants have recently been dosed in the randomized, double-blind, placebo-controlled study (ASC47-103 study, NCT06972992) ...
In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research ...
People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...
22h
GB News on MSNWeight loss jabs could be key to shrinking breast cancer tumours as scientists discover dual benefitA weight loss drug has been found to dramatically reduce breast cancer tumour growth while still achieving significant weight ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
SAN FRANCISCO -- Menopause hormone therapy (MHT) was tied to a weight-loss boost in postmenopausal women taking a weight loss ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results